ReviewPharmaceutics2024

Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review.

Ting-Yu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.